We constructed the aberrantly expressed and mutational landscape of PAAD and identified a series of targetable antigens, of which ADAM9, EFNB2, MET, TPX2, TMOD3 and WNT7A are promising mRNA vaccine candidates. This evidence concerns the gene MET and pancreatic adenocarcinoma.